MacroGenics | Rentekostnader



Interest Expense On Debt Endring Dato
AbbVie USD 610M 19M 2024-12
Amgen USD 747M 29M 2024-12
AstraZeneca 429M 28M 2024-12
Biogen USD 60M 200K 2024-12
Bristol-Myers Squibb USD 496M 9M 2024-12
Daiichi Sankyo 11.62B 11.42B 2024-09
Eli Lilly USD 224.7M 78.4M 2024-12
Genmab DKK 2.68B 1.98B 2024-12
Geron USD 8.71M 5.66M 2024-12
Gilead Sciences USD 248M 10M 2024-12
J&J USD 137M 56M 2024-12
MacroGenics USD -24000 24K 2024-12
Merck USD 328M 2M 2024-12
Pfizer USD 739M 45M 2024-12
Regeneron Pharmaceuticals USD 10.5M 3.3M 2024-12
Roche Holding CHF 311.5M 1000K 2024-12
Xencor -39359000 40.15M 2024-12



MacroGenics Rentekostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.